| Literature DB >> 34938920 |
Jing Wang1,2, He Qiu3, Yang Xu1,2, Yongli Gao1,2, Peijie Tan3, Rui Zhao3, Zhanhong Liu1,2, Yajun Tang1,2, Xiangdong Zhu1,2, Chongyun Bao3, Hang Wang3, Hai Lin1,2, Xingdong Zhang1,2.
Abstract
The application of medical devices to repair skin damage is clinically accepted and natural polymer enjoys an important role in this field, such as collagen or hyaluronic acid, etc. However, the biosafety and efficacy of these implants are still challenged. In this study, a skin damage animal model was prepared by UV-photoaging and recombinant humanized type III collagen (rhCol III) was applied as a bioactive material to implant in vivo to study its biological effect, comparing with saline and uncrosslinked hyaluronic acid (HA). Animal skin conditions were non-invasively and dynamically monitored during the 8 weeks experiment. Histological observation, specific gene expression and other molecular biological methods were applied by the end of the animal experiment. The results indicated that rhCol III could alleviate the skin photoaging caused by UV radiation, including reduce the thickening of epidermis and dermis, increase the secretion of Collagen I (Col I) and Collagen III (Col III) and remodel of extracellular matrix (ECM). Although the cell-material interaction and mechanism need more investigation, the effect of rhCol III on damaged skin was discussed from influence on cells, reconstruction of ECM, and stimulus of small biological molecules based on current results. In conclusion, our findings provided rigorous biosafety information of rhCol III and approved its potential in skin repair and regeneration. Although enormous efforts still need to be made to achieve successful translation from bench to clinic, the recombinant humanized collagen showed superiorities from both safety and efficacy aspects.Entities:
Keywords: Biological effect; Recombinant collagen; Safety and efficacy; Skin regeneration; Type III collagen
Year: 2021 PMID: 34938920 PMCID: PMC8665261 DOI: 10.1016/j.bioactmat.2021.10.004
Source DB: PubMed Journal: Bioact Mater ISSN: 2452-199X
The main information of experimental groups and implants.
| Groups | Surgical Area Number | UV Radiation | Implants (Concentration; Volume) |
|---|---|---|---|
| Normal | 10 | – | None |
| Blank Control | 10 | + | None |
| Negative Control | 10 | + | Saline (0.9%; 1 mL) |
| Uncrosslinked HA | 10 | + | Uncrosslinked Hyaluronic Acid (2.0 mg/mL; 1 mL) |
| L-rhCol III (Low Concentration) | 10 | + | rhCol III (0.8 mg/mL; 1 mL) |
| M-rhCol III (Medium Concentration) | 10 | + | rhCol III (2.0 mg/mL; 1 mL) |
| H-rhCol III (High Concentration) | 10 | + | rhCol III (3.2 mg/mL; 1 mL) |
The primer sequences of the target gene for RT-qPCR.
| Gene name | Direction | Sequence(5,-3) |
|---|---|---|
| Col Ⅰ | Forward | GAGAACCAGCAGAGCCA |
| Reverse | GAACAAGGTGACAGAGGCATA | |
| Col Ⅲ | Forward | GTGCTACTGTGAGCTGCTTCTTC |
| Reverse | TCTACATTGGACTGCTGTGCC | |
| Elastin | Forward | GGTGATCTTGGAGGAGCAGG |
| Reverse | CCAGCTCCAAATCCAGGGAC | |
| MMP-3 | Forward | AATGGTCTTGGCTCATGCCT |
| Reverse | AGGAATAGGTTGGTACCTGTGAC | |
| GAPDH | Forward | AGACAGCCGCATCTTCTTGT |
| Reverse | TTCCCATTCTCAGCCTTGAC |
MMP-3: Matrix Metalloproteinase-3.
Fig. 1Skin condition detected by CBS skin analysis system (a, Optical images captured by CBS skin analysis system (up) and negative images processed by CBS skin analysis system (down). b: Change of collagen content in the skin. c: Change of skin elasticity. d: Change of oil content in the skin).
Fig. 2Skin condition detected by ultrasonic inspection (a: Macroscopic appearance and ultrasonic image before and after dermal injection. b: Changes of dermis thickness. c: Changes of dermis density.).
Fig. 3Histological images and analysis (a: H&E staining. Scale bars: 500 μm. b: Changes of epidermis thickness. c: Changes of dermis thickness. d: Proportion of total adipocyte area.).
Fig. 4Sirius Red staining and analysis (a: Sirius Red staining images. Scale bars: 50 μm. b: Proportion of Col I. c: Proportion of Col III.)
Fig. 5Relative gene expression determined by RT-qPCR (a–d: Col I, Col III, Elastin and MMP3).
Fig. 6Analysis of SOD, MDA and Hyp.